NMC Health plc
NMMCF · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.94 | 1.97 | 1.16 | 15.60 |
| FCF Yield | 2.98% | 2.06% | 1.23% | 0.05% |
| EV / EBITDA | 19.52 | 34.45 | 41.81 | 72.04 |
| Quality | ||||
| ROIC | 10.62% | 10.21% | 8.71% | 8.58% |
| Gross Margin | 40.89% | 39.63% | 38.29% | 34.62% |
| Cash Conversion Ratio | 1.51 | 1.32 | 1.16 | 0.99 |
| Growth | ||||
| Revenue 3-Year CAGR | 19.00% | 22.10% | 23.77% | 16.94% |
| Free Cash Flow Growth | 4.79% | 82.80% | 2,642.27% | 116.58% |
| Safety | ||||
| Net Debt / EBITDA | 3.57 | 3.58 | 2.38 | 4.41 |
| Interest Coverage | 3.38 | 4.57 | 5.70 | 5.58 |
| Efficiency | ||||
| Inventory Turnover | 4.92 | 5.34 | 5.22 | 4.27 |
| Cash Conversion Cycle | 124.55 | 132.54 | 126.93 | 144.02 |